EQS-News: Immunic to Participate in Investor and Scientific Conferences in February
February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic ...
Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at ...
Rubber World3d
The Rubber Division announces a Call for Abstracts for the Global Polymer Summit in Cleveland this September
The Rubber Division invites your submissions for inclusion in our Global Polymer Summit Technical Meeting & Student Symposium, September 9-11 in Cleveland, OH. Combining the strengths of Rubber ...
TankerOperator4d
Call for abstracts for Rotterdam symposium on maritime health in June
ISMH17 will be held in Rotterdam, The Netherlands offering opportunities for professionals in or related to maritime health to present their research and share valuable insights. Your submission will ...
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster ...